Sepanlou SG, Bisignano. SS. The global, regional, and National burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol. 2020;5:245–66. https://doi.org/10.1016/s2468-1253(19)30349-8.
Younossi ZM. Non-alcoholic fatty liver disease - a global public health perspective. J Hepatol. 2019;70:531. https://doi.org/10.1016/j.jhep.2018.10.033.
Younossi ZM, Golabi P, Paik JM, et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77:1335–47. https://doi.org/10.1097/hep.0000000000000004.
Article PubMed PubMed Central Google Scholar
Byrne CD, Targher G. Nafld: a multisystem disease. J Hepatol. 2015;62:S47-64. https://doi.org/10.1016/j.jhep.2014.12.012.
Pouwels S, Sakran N, Graham Y, et al. Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss. BMC Endocr Disord. 2022;22:63. https://doi.org/10.1186/s12902-022-00980-1.
Article CAS PubMed PubMed Central Google Scholar
Vancells Lujan P, Viñas Esmel E, Sacanella Meseguer E. Overview of non-alcoholic fatty liver disease (NAFLD) and the role of sugary food consumption and other dietary components in its development. Nutrients. 2021;13:1442. https://doi.org/10.3390/nu13051442.
Article CAS PubMed PubMed Central Google Scholar
Trovato FM, Martines GF, Brischetto D, et al. Fatty liver disease and lifestyle in youngsters: diet, food intake frequency, exercise, sleep shortage and fashion. Liver Int. 2016;36:427–33. https://doi.org/10.1111/liv.12957.
Article CAS PubMed Google Scholar
Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79:1542–56. https://doi.org/10.1016/j.jhep.2023.06.003.
Article CAS PubMed Google Scholar
Song SJ, Lai JC, Wong GL, et al. Can we use old NAFLD data under the new MASLD definition? J Hepatol. 2024;80:54–6. https://doi.org/10.1016/j.jhep.2023.07.021.
Milošević N, Milanović M, Medić Stojanoska M, et al. Triterpenoids from Chios Mastiha Resin against MASLD-a molecular docking survey. Curr Issues Mol Biol. 2025;47:51. https://doi.org/10.3390/cimb47010051.
Article CAS PubMed PubMed Central Google Scholar
Ciardullo S, Muraca E, Vergani M, et al. Advancements in pharmacological treatment of NAFLD/MASLD: a focus on metabolic and liver-targeted interventions. Gastroenterol Rep (Oxf). 2024;12:goae029. https://doi.org/10.1093/gastro/goae029.
Article PubMed PubMed Central Google Scholar
Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67:328–57. https://doi.org/10.1002/hep.29367.
Malhotra A, White DP. Obstructive sleep apnoea. Lancet. 2002;360:237–45. https://doi.org/10.1016/s0140-6736(02)09464-3.
Shah NM, Malhotra AM, Kaltsakas G. Sleep disorder in patients with chronic liver disease: a narrative review. J Thorac Dis. 2020;12:248–60. https://doi.org/10.21037/jtd-cus-2020-012.
Bernsmeier C, Weisskopf DM, Pflueger MO, et al. Sleep disruption and daytime sleepiness correlating with disease severity and insulin resistance in non-alcoholic fatty liver disease: a comparison with healthy controls. PLoS One. 2015;10:e0143293. https://doi.org/10.1371/journal.pone.0143293.
Article CAS PubMed PubMed Central Google Scholar
Yang J, Luo S, Li R, et al. Sleep factors in relation to metabolic dysfunction-associated fatty liver disease in middle-aged and elderly Chinese. J Clin Endocrinol Metab. 2022;107:2874–82. https://doi.org/10.1210/clinem/dgac428.
Zarean E, Looha MA, Amini P, et al. Sleep characteristics of middle-aged adults with non-alcoholic fatty liver disease: findings from the Shahrekord PERSIAN cohort study. BMC Public Health. 2023;23:312. https://doi.org/10.1186/s12889-023-15251-4.
Article PubMed PubMed Central Google Scholar
Bonsignore MR, Borel AL, Machan E, et al. Sleep apnoea and metabolic dysfunction. Eur Respir Rev. 2013;22:353–64. https://doi.org/10.1183/09059180.00003413.
Article PubMed PubMed Central Google Scholar
Kim T, Choi H, Lee J, et al. Obstructive sleep apnea and nonalcoholic fatty liver disease in the general population: a cross-sectional study using nationally representative data. Int J Environ Res Public Health. 2022;19:8398. https://doi.org/10.3390/ijerph19148398.
Article PubMed PubMed Central Google Scholar
Krolow GK, Garcia E, Schoor F, et al. Obstructive sleep apnea and severity of nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2021;33:1104–9. https://doi.org/10.1097/meg.0000000000001920.
Article CAS PubMed Google Scholar
Marin-Alejandre BA, Abete I, Cantero I, et al. Association between sleep disturbances and liver status in obese subjects with nonalcoholic fatty liver disease: a comparison with healthy controls. Nutrients. 2019;11:322. https://doi.org/10.3390/nu11020322.
Article CAS PubMed PubMed Central Google Scholar
Stanojevic C, Simic S, Milutinovic D. Health effects of sleep deprivation on nurses working shifts. Med Pregl. 2016;69:183–8. https://doi.org/10.2298/mpns1606183s.
Okamura T, Hashimoto Y, Hamaguchi M, et al. Short sleep duration is a risk of incident nonalcoholic fatty liver disease: a population-based longitudinal study. J Gastrointestin Liver Dis. 2019;28:73–81. https://doi.org/10.15403/jgld.2014.1121.281.alc.
Miyake T, Kumagi T, Furukawa S, et al. Short sleep duration reduces the risk of nonalcoholic fatty liver disease onset in men: a community-based longitudinal cohort study. J Gastroenterol. 2015;50:583–9. https://doi.org/10.1007/s00535-014-0989-0.
Kim JH, Jung DH, Kwon YJ, et al. The impact of the sleep duration on NAFLD score in Korean middle-aged adults: a community-based cohort study. Sleep Med. 2019;57:144–50. https://doi.org/10.1016/j.sleep.2019.02.012.
Article CAS PubMed Google Scholar
Marjot T, Ray DW, Williams FR, et al. Sleep and liver disease: a bidirectional relationship. Lancet Gastroenterol Hepatol. 2021;6:850–63. https://doi.org/10.1016/s2468-1253(21)00169-2.
Sun Z, Ji J, Zuo L, et al. Causal relationship between nonalcoholic fatty liver disease and different sleep traits: a bidirectional Mendelian randomized study. Front Endocrinol (Lausanne). 2023;14:1159258. https://doi.org/10.3389/fendo.2023.1159258.
Article PubMed PubMed Central Google Scholar
Faulkner G, Fagan MJ, Lee J. Umbrella reviews (systematic review of reviews). Int Rev Sport Exerc Psychol. 2022;15:73–90. https://doi.org/10.1080/1750984X.2021.1934888.
Aromataris E, Fernandez R, Godfrey CM, et al. Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach. Int J Evid Based Healthc. 2015;13:132–40. https://doi.org/10.1097/xeb.0000000000000055.
Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008. https://doi.org/10.1136/bmj.j4008.
Comments (0)